Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 468, pseudogene (RN7SL468P), is a non-coding RNA locus classified as a pseudogene in the human genome[11][9]. It is related to the functional 7SL RNA gene, which provides the RNA component of the signal recognition particle (SRP) complex—a ribonucleoprotein involved in the co-translational targeting of proteins to membranes[1]. Unlike the functional 7SL RNA gene, RN7SL468P does not produce a functional RNA molecule or protein[11][3][5]. Pseudogenes such as RN7SL468P largely arise from reverse transcription and reintegration of RNA sequences and accumulate mutations or truncations that preclude functional expression[3][5]. Although some pseudogenes can have regulatory impact by producing antisense RNA transcripts that modulate gene expression or participate in small interfering RNA (siRNA) pathways in various contexts, there is no evidence of such regulatory function specific to RN7SL468P[6][8][11]. In summary, RN7SL468P is a well-characterized pseudogene, not a receptor, enzyme, or therapeutic target, and serves no established molecular or disease-related role[11][9][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 468, pseudogene (RN7SL468P).